Sustainable Anaesthesia

Sintetica is an uncompromising and remarkable organisation

Sintetica sees sustainability and the environment as its essential fabric, only using energy from 100% renewable sources in the manufacture of its medicines. Manufacturing to the strict standards of Swiss, European, US and international agencies, continuously supplying our customers on time every time across the globe, Sintetica is dedicated to being the world leader in sustainable anaesthesia


Renewable sources

Why should sustainable sourcing
by Sintetica matter to you?

Sustainable sourcing goes one step further than ethical sourcing, sustainable sourcing is the combination of social, ethical and environmental factors in the supply chain.
One of the most distinctive features of Sintetica is putting people first. Starting by putting people first in the workplace of Sintetica engenders a greater global approach to improving holistic healthcare, protecting the environment and long-term sustainability.
The sustainability commitment of Sintetica unfolds in our supply chain. We only select suppliers from within Switzerland and our neighbours in the EEA to ensure Sintetica’s Ethical Code is upheld; comprising: human-centricity, manufactured products and the manufacturing process, energy renewal, our environment, recycling, waste and packaging.

All of our waste products are sorted and recycled.

All packaging is recyclable, including the inert PVC-free plastics used in our ampoules of ropivacaine.

All medicines produced in plastics by Sintetica are PVC-free and recyclable.

Do you care about energy sources in the medicines you choose?

Sintetica only uses energy which is 100% certified as coming from renewable energy sources. Sintetica has an extensive photovoltaic system covering one thousand square metres on the roof of our company headquarters and manufacturing facility in Mendrisio, Switzerland. By only using renewable energy Sintetica is protecting the environment for future generations.

Sintetica and environmental protection


Increasing production


CO2 emissions
Despite increasing production by 55% and adding new production lines, Sintetica’s investment in state-of-the-art plant and equipment has produced a fall in CO2 emissions. By using more efficient and energy consuming equipment Sintetica has dropped its CO2 emissions by 13%.


The cubic metres of water used per vial


The cubic metres of water used in production
By designing and installing one of the world’s most advanced manufacturing and production facilities Sintetica is: reducing the cubic metres of water used per vial by 4.2% reducing the cubic metres of water used in production by 35.3% is able to recycle all of the water used in production.

Our desire to protect the environment has driven us to reach the very highest standards of manufacturing and production, which protects the environment for future generations.

At Sintetica we know there is no planet B

Sintetica, founded in 1921, has in its legacy specialist anaesthetics and analgesics that are manufactured in Switzerland, continuously supplied to its markets and integrated into healthcare pathways by people with a real passion and ethical responsibility for what they do.

Under the leadership of Augusto Mitidieri, Corporate CEO, Sintetica is ready to celebrate the next centenary, shaping the future of sustainable anaesthesia as world leader.

Careful choice of anaesthetic can help save the planet

Hip replacements performed under regional rather than general anaesthetic might help to reduce global warming, a study has reported.

Experts said that the findings added to evidence of the environmental benefits of new techniques — NHS doctors are already applying the lessons of previous research.

The study found that gases used by anaesthetists, such as desflurane and nitrous oxide, could result in thousands of times the environmental damage caused by carbon dioxide.

The study, published in Regional Anesthesia & Pain Medicine, an American journal, was based on 10,485 hip and knee replacements at the Hospital for Special Surgery in New York last year. Only 419 (4 per cent) were done under general anaesthetic, with the rest carried out using regional anaesthesia, involving a local nerve block and intravenous sedatives. The researchers said that US hospitals typically performed 75 per cent of the operations under general anaesthetic.

The researchers calculated that the change had "saved" the equivalent of almost 27,000lb (12,250kg) of coal being burnt.

Regional anaesthesia also provides more effective pain relief and fewer side-effects, the researchers said, and hospital stays were shorter. The study acknowledged that not all operations could be carried out without general anaesthesia.

"There is alignment between optimal anaesthetic technique and wider societal goals," they said. "Increasing the use of regional anaesthesia is potentially good for the climate, improves the quality of care (at least for hip and knee replacements) and may allow individual practitioners to take personal responsibility in the fight against global warming."

Anaesthesia for surgery can broadly be performed using three techniques Tom Pierce, the Royal College of Anaesthetists’ environmental adviser to the president, said. These are general anaesthesia through the inhalation of vapours, intravenous delivery of drugs, or regional anaesthesia with a spinal block, often accompanied by intravenous sedatives.

Dr Pierce said that it was not simple to translate the paper’s figures to Britain because American anaesthetists tended to use gases at higher flow rates, under rules set out by the Food and Drug Administration. Differences between the sources of electricity in countries resulted in a large variation in operations' carbon footprints, he said.

However, he added: "Anaesthetics do have a global warming effect. Can we convincingly show that regional anaesthetic techniques are better? The answer is, I can do calculations with the various tools I've made and say, yes it does, even when you allow for the plastics that have to be used to administer the drugs for the local anaesthesia."

He said that the use of nitrous oxide in Britain was already falling. In his own Southampton hospital, use in 2018 was about 30 per cent of what it was in 2010.

"There is a groundswell of interest among younger anaesthetists," he said. "They are absolutely fired up by this."

About 75,000 hip replacements are performed in Britain each year, although tightened referral criteria led to a fall in numbers last year and Covid-19 will have increased waiting lists.

Kat Lay, Health Correspondent
Wednesday June 17 2020, 12.00am BST, The Times
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.